Reviewer’s Comment: Patients were stratified by concurrent vs sequential trastuzumab therapy. It is important to note that most patients in the United States are currently treated with concurrent trastuzumab therapy in the adjuvant setting. Exceptions may be if the HER2 status changes throughout the course of therapy, which may occur.